Item 7.01 Regulation FD Disclosure.
On
The information contained in this Item 7.01 of the Form 8-K, including Exhibit 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is not incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press Release, datedAugust 4, 2022 The cover page fromMarker Therapeutics, Inc.'s Form 8-K filed on 104August 4, 2022 , formatted in Inline XBRL
© Edgar Online, source